Organisation: Endologix, LLC and Cleveland Clinic Foundation
Position: Vascular surgeon and Chief Medical Officer
Is endovascular aortic aneurysm treatment a failed experiment or a blessing to the patient
Is endovascular aortic aneurysm treatment a failed experiment or a blessing to the patient. Topics to be explored will be the change in aortic services that have accompanied the introduction of EVAR, the impact to patients and the evolution of the therapy
Biography
Professor Matt Thompson is Chief Medical Officer for Endologix LLC, and a Staff Surgeon, Department of Vascular Surgery, Cleveland Clinic Foundation. Previously he was the Professor of Vascular Surgery at St George’s, University of London.
His clinical interests are in the treatment of aortic disease and endovascular surgery. Research interests include health service outcome research, clinical trials and translational investigations into aortic disease. Professor Thompson is the editor of the Oxford Textbook of Vascular Surgery and the Oxford Handbook of Vascular Surgery and has a lifetime achievement award from the VSGBI.
He has been the clinical director for three London-wide service reconfigurations (cardiovascular disease, major trauma and emergency services). He was Chair of the National Specialized Commissioning Group for Vascular Services. He is a founder of the British Society for Endovascular Therapy, a past Council Member of the VSBGI
